Anne Kelso | |
---|---|
Born | 1954 (age 69–70) |
Alma mater | University of Melbourne |
Scientific career | |
Institutions | National Health and Medical Research Council |
Anne Kelso (born 1954) [1] is an Australian biomedical researcher specialising in immunology and influenza. She is the Chief Executive Officer of the Australian Government's National Health and Medical Research Council (NHMRC).
Kelso obtained her Bachelor of Science (Honours) in 1975 and PhD in immunology in 1980 at the University of Melbourne. [2]
Following postdoctoral research at the Swiss Institute for Experimental Cancer Research, Kelso undertook research in the laboratories of Donald Metcalf and Gustav Nossal at the Walter and Eliza Hall Institute of Medical Research (1982-1992) and then the Queensland Institute of Medical Research (now QIMR Berghofer Medical Research Institute) (1992-2007). Kelso was also Director/CEO of the Cooperative Research Centre for Vaccine Technology from 2000 until 2006. In 2007, she returned to Melbourne as Director of the WHO Collaborating Centre for Reference and Research on Influenza until 2015 when she took up the role of CEO of the National Health and Medical Research Council. [3] Her appointment was renewed for a further five years in 2018.
Kelso has previously served as president of the Australasian Society for Immunology, as Secretary-General of the International Union of Immunological Societies, and as a member of several governing boards and advisory groups, including the Council of QUT and the boards of the Telethon Kids Institute and the Florey Institute of Neuroscience and Mental Health. She has also served on committees advising the World Health Organization and the Australian Government on influenza. [4]
As CEO of NHMRC, Kelso oversees the agency’s activities to improve the health of the Australian community through: investment in health and medical research in Australian universities, medical research institutes and hospitals; translation of research into policy and practice through clinical, public health and environmental health guidelines; development of guidelines on ethical practice in health care and the conduct of health and medical research; and administration of legislation regulating research using human embryos. She also represents NHMRC on the Board of Trustees of the Human Frontier Science Programme Organization and the Strategy Board of the Global Alliance for Chronic Diseases.
Kelso’s key focus areas have been the restructure of NHMRC’s grant program, developments in NHMRC’s peer review processes, and initiatives to improve gender equality in health and medical research.
Kelso undertook research on the regulation of T lymphocyte effector function, particularly the cellular and molecular control of cytokine synthesis and cytolytic activity. As Director of the WHO Collaborating Centre for Reference and Research on Influenza, she was also part of a collaborative research team working on T cell immunity to influenza viruses. The Australian Academy of Science recognises her research contributions to Australian science as "wide-ranging and significant". [5]
Kelso holds an honorary professorial appointment in the Department of Microbiology and immunology at the University of Melbourne.
Kelso was appointed Officer an Officer of the Order of Australia in the 2007 Queen's Birthday Honours for "service to science, particularly in the field of immunology and vaccine research through contributions to a range of scientific organisations, and as an academic and mentor". [6]
In 2018, Kelso was elected Fellow of the Australian Academy of Science [5] and Fellow of the Australian Academy of Health and Medical Sciences. [7]
WEHI, previously known as the Walter and Eliza Hall Institute of Medical Research, and as the Walter and Eliza Hall Institute, is Australia's oldest medical research institute. Sir Frank Macfarlane Burnet, who won the Nobel Prize in 1960 for his work in immunology, was director from 1944 to 1965. Burnet developed the ideas of clonal selection and acquired immune tolerance. Later, Professor Donald Metcalf discovered and characterised colony-stimulating factors. As of 2015, the institute hosted more than 750 researchers who work to understand, prevent and treat diseases including blood, breast and ovarian cancers; inflammatory diseases (autoimmunity) such as rheumatoid arthritis, type 1 diabetes and coeliac disease; and infectious diseases such as malaria, HIV and hepatitis B and C.
Jacques Francis Albert Pierre Miller AC FRS FAA is a French-Australian research scientist. He is known for having discovered the function of the thymus and for the identification of mammalian species of the two major subsets of lymphocytes and their function.
Michael F. Good was the Director of the Queensland Institute of Medical Research, from 2000 to 2010. He was Chair of the National Health and Medical Research Council.
The Ian Constable Lecture is an annual lecture given in Perth, Western Australia.
The Sir William Dunn School of Pathology is a department within the University of Oxford. Its research programme includes the cellular and molecular biology of pathogens, the immune response, cancer and cardiovascular disease. It teaches undergraduate and graduate courses in the medical sciences.
Christopher Carl Goodnow is an immunology researcher and the current executive director of the Garvan Institute of Medical Research. He holds the Bill and Patricia Ritchie Foundation Chair and is a Conjoint Professor in the faculty of medicine at UNSW Sydney. He holds dual Australian and US citizenship.
Sir Gordon William Duff, is a British medical scientist and academic. He was principal of St Hilda's College, Oxford, from 2014 to 2021. He was Lord Florey Professor of Molecular Medicine at the University of Sheffield from 1991 to 2014.
Douglas James Hilton is an Australian molecular biologist. He is the CEO of CSIRO and immediate past Director of the Walter and Eliza Hall Institute of Medical Research in Melbourne, Australia. His research has focused on cytokines, signal transduction pathways and the regulation of blood cell formation (hematopoiesis). Hilton was the President of the Association of the Australian Medical Research Institutes (AAMRI) from 2014-16.
Brendan Scott Crabb is an Australian microbiologist, research scientist and director and chief executive officer of the Burnet Institute, based in Melbourne, Victoria, Australia.
Aleksandra Filipovska is an Australian scientist who is a professor, Deputy Director of the ARC Centre of Excellence in Synthetic Biology and NHMRC Investigator at the University of Western Australia, heading a research group at the Telethon Kids Institute. Specializing in biochemistry and molecular biology, she has made contributions to the understanding of human mitochondrial genetics in health and disease.
Jennifer Lea Stow is deputy director (research), NHMRC Principal Research Fellow and head of the Protein Trafficking and Inflammation laboratory at the Institute for Molecular Bioscience (IMB), The University of Queensland, Australia. She received a PhD from Monash University in Melbourne in 1982, postdoctoral training at Yale University School of Medicine (US) in the Department of Cell Biology. Her first faculty position was as an assistant professor at Harvard University in the Renal Unit, Departments of Medicine and Pathology at the Massachusetts General Hospital in Boston.
Julie Bernhardt is an Australian physiotherapist and clinician scientist, known for her work in the field of stroke recovery. She has been a principal research fellow and an NHMRC senior research fellow and clinical head of the Stroke Division at the Florey Institute of Neuroscience and Mental Health, University of Melbourne.
Elizabeth Scarr is an Australian scientist. Her research investigates the chemical changes in the brain associated schizophrenia and bipolar disorder.
Keryn Anne Williams is an Australian medical scientist who works in the field of ophthalmology. She was a Principal Research Fellow in the School of Medicine at Flinders University. Her research interests include clinical and experimental corneal transplantation, ocular inflammation, ocular immunology and eye banking.
Misty Rayna Jenkins is an Australian scientist known for her research into lymphocytes and cancer treatment.
Sarah Anne Robertson is an Australian biologist who is a fellow of both the Australian Academy of Science and Australian Academy for Health and Medical Sciences, and Professor of Reproductive Immunology at University of Adelaide, Australia, and Director of the Robinson Research Institute. She was an NHMRC fellow for more than 15 years.
Carol Shoshkes Reiss, an American viral immunologist, was a professor at New York University's Department of Biology between 1991 and 2020. She is currently a professor emerita at New York University. Her research focused on the dynamic contest between the mouse immune system and virus replication during central nervous system infection. Reiss was editor-in-chief of the journal Viral Immunology (2000–2006) and is currently editor-in-chief of the journal DNA and Cell Biology (2012–present).
Laura K. Mackay is an Australian immunologist and Professor of Immunology at the University of Melbourne. Mackay is the Theme Leader in Immunology and Laboratory Head at the Peter Doherty Institute for Infection and Immunity. In 2022, she was the youngest Fellow elected to the Australian Academy of Health and Medical Sciences.
Emily Banks is an Australian epidemiologist and public health physician, working mainly on chronic disease. She is a Professor of Epidemiology and Public Health and Head of the Centre for Public Health Data and Policy at the Australian National University, and a visiting professor at the University of Oxford.
Fabienne Mackay is a French Australian research immunologist and institutional leader within the Australian medical research, education and innovation sectors. She is the Director and CEO of the QIMR Berghofer Medical Research Institute since 2020, after being the inaugural Head of the School of Biomedical Sciences at the University of Melbourne during the preceding five years. She is also an Honorary Professor at the Faculties of Medicine of the University of Queensland and the University of Melbourne. Her work has attracted public attention for its contribution to the pathophysiological understanding and treatment of lupus and other autoimmune diseases. Mackay has been notably awarded, achieving international reputation for her widely cited research describing B-cell activating factor (BAFF) and other cytokines of the TNF receptor superfamily, and their roles in B cell physiology, autoimmunity and cancer. She is an elected Fellow of the Australian Academy of Health and Medical Sciences.